REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Prywatna Magdalena Krasicka-Tytula sp. j. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Household Appliances and Electrical and Electronic Goods Merchant Wholesalers | Retail Trade | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Rental and Leasing Services | Advertising Agencies
Full name: Apteka Prywatna Magdalena Krasicka-Tytula sp. j. Profile Updated: March 06, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Apteka Prywatna Magdalena Krasicka-Tytula sp. j. is a company based in Poland, with its head office in Przeworsk. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on June 28, 2002.

Headquarters
Ul. Lwowska 6
Przeworsk; Podkarpackie; Postal Code: 37-200

Contact Details: Purchase the Apteka Prywatna Magdalena Krasicka-Tytula sp. j. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Prywatna Magdalena Krasicka-Tytula sp. j. report to view the information.
Incorporation Date:
June 28, 2002
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Apteka Prywatna Magdalena Krasicka-Tytula sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total assets
0%
Total equity
0%
Return on Equity (ROE)
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?